Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/03009742.2021.1926318
PubMed Identifier: 34474634
Publication URI: http://europepmc.org/abstract/MED/34474634
Type: Journal Article/Review
Volume: 51
Parent Publication: Scandinavian journal of rheumatology
Issue: 2
ISSN: 0300-9742